top of page
Search Results

197 items found for "POTS"

  • Decoding β-Arrestins: from Structure to function

    arises that GPCR and β-arrestin-centered effector complexes vary based on subcellular localization, potentially Furthermore, the temporal dynamics of β-arrestin subcellular localization, leading to variations in potential Recent advancements in experimental and bioinformatics tools offer the potential to explore larger portions Such alterations can also extend to β-arrestin expression levels, potentially affecting the composition

  • 📰 GPCR Weekly News, August 7 to 13, 2023

    regulates avoidance and stress-induced sleep in Caenorhabditis elegans Towards the convergent therapeutic potential : a study based on RNA-seq Reviews, GPCRs, and more Tri-part NanoLuc as a new split technology with potential

  • 📰 GPCR Weekly News, July 17 to July 23, 2023

    Encoded As An Autoproteolysis Event in Adhesion G Protein-Coupled Receptor Latrophilin-3/ADGRL3. mthl1, a potential Addex Mglu2pam Demonstrates Potential In Substance Use Disorder.

  • 📰 GPCR Weekly News, July 10 to 16, 2023

    GPCR Binders, Drugs, and more Allosteric modulator potentiates β2AR agonist-promoted bronchoprotection The potent BECN2-ATG14 coiled-coil interaction is selectively critical for endolysosomal degradation

  • 📰 GPCR Weekly News, June 26 to July 2, 2023

    GPCRs in Cardiology, Endocrinology, and Taste Adipocyte G Protein-Coupled Receptors as Potential Targets Multi-omics integration analysis of GPCRs in pan-cancer to uncover inter-omics relationships and potential Structural and Molecular Insights into GPCR Function Identification of a potential structure-based GPCR

  • Structural landscape of the Chemokine Receptor system

    2023), which provide extra negative charges to the N-terminus thereby increasing binding affinity and potency

  • 📰 GPCR Weekly News, June 12 to 18, 2023

    GPCRs in Neuroscience Orphan receptor GPR88 as a potential therapeutic target for CNS disorders - an

  • 📰 GPCR Weekly News, June 5 to 11, 2023

    Regulation of the length of neuronal primary cilia and its potential effects on signalling.

  • 📰 GPCR Weekly News, May 22 to 28, 2023

    Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • 📰 GPCR Weekly News, May 15 to 21, 2023

    Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • 📰 GPCR Weekly News, May 8 to 14, 2023

    An allosteric modulator of the adenosine A1 receptor potentiates the antilipolytic effect in rat adipose Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • Artificial intelligence – faster, smarter, cheaper GPCR drug discovery

    The integration of AI in GPCR drug discovery has the potential to accelerate the identification and development Side effect prediction and clinical responses: AI can predict potential off-target effects and adverse By analyzing drug-target interactions and disease pathways, AI can identify potential candidates that Pros and cons of current technology AI has the potential to revolutionize drug discovery by accelerating While AI holds great potential, it is important to note that it is not a replacement for experimental

  • 📰 GPCR Weekly News, May 1 to 7, 2023

    Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • 📰 GPCR Weekly News, April 24 to 30, 2023

    Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • 📰 GPCR Weekly News, April 17 to 23, 2023

    GPCRs in Oncology and Immunology CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • 📰 GPCR Weekly News, April 10 to 16, 2023

    Annual GPCRs-Targeted Drug Discovery Summit, Boston MA Pathios Therapeutics Unveils PTT-4256, a Highly Potent Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • 📰 GPCR Weekly News, April 3 to 9, 2023

    GPCRs in Neuroscience G protein-coupled receptors (GPCRs) as Potential Therapeutics for Psychiatric Disorders Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • 📰 GPCR Weekly News, March 27 to April 4, 2023

    GPCR Activation and Signaling Butyrate potentiates Enterococcus faecalis lipoteichoic acid-induced inflammasome Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities. Investigating the potential of GalR2 as a drug target for neuropathic pain. Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • 📰 GPCR Weekly News, March 20 to 26, 2023

    Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • 📰 GPCR Weekly News, March 13 to 19, 2023

    GPCRs in Oncology and Immunology Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists Reviews, GPCRs, and more The leukotriene B4 receptors BLT1 and BLT2 as potential therapeutic targets. Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • 📰 GPCR Weekly News, March 6 to 12, 2023

    Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • 📰 GPCR Weekly News, February 27 to March 5, 2023

    Methods & Updates in GPCR Research Time- and cost-efficient bacterial expression and purification of potato Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • 📰 GPCR Weekly News, February 20 to 26, 2023

    Activation and Signaling Coupling between GPR143 and dopamine D2 receptor is required for selective potentiation on dopamine D2 receptor ligand binding and signaling GPCR Binders, Drugs, and more Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite Loss. GPCRs in Cardiology, Endocrinology, and Taste α1-Adrenergic Receptors: Insights into Potential Therapeutic Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • Regulators of G-protein signaling: essential players in GPCR signaling

    mutations in the RGS domain and other structural motifs have been shown to alter the specificity and potency et al., Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential

  • 📰 GPCR Weekly News, February 13 to 19, 2023

    Octopamine and tyramine signalling in Aedes aegypti: Molecular characterization and insight into potential GPCR Binders, Drugs, and more Novel targets for potential therapeutic use in Diabetes mellitus. Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • Glyco-sulfo hotspots in the chemokine receptor system

    This effect could be driven by a specific carrier or it can potentially be related with the increase biology and pharmacology however the reported effects can vary depending on the receptor-ligand pairs and potentially also reported that PSGL-1 glycosulfo peptide analogue GSnP-6 displays nanomolar affinity and promising potential

  • 📰 GPCR Weekly News, February 6 to 12, 2023

    Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

  • New role of β-arrestins in MOR signaling

    activation is generally related to inhibiting neurotransmission by hyperpolarizing the cell or reducing or potentiating

bottom of page